GlassScriptPhysician profile
Robin Yadav
NPI 1801403241
$624.22
in general payments reported to CMS, 2019-2025
9 companies · $606 in 2025
The $606 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.21 · 2025: $606.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $606.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $606.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $246.38 | 2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $116.25 | 2025 | |
| Dendreon Pharmaceuticals LLC | $95.59 | 2025 | Provenge |
| Sumitomo Pharma America, INC. | $46.22 | 2025 | Gemtesa |
| Immunitybio, INC. | $34.66 | 2025 | |
| Medtronic, INC. | $28.11 | 2025 | Emprint |
| Antares Pharma, INC. | $20.09 | 2025 | Xyosted |
| Astellas Pharma US INC | $18.71 | 2025 | Xtandi |
| Tactile Systems Technology INC | $18.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Yadav listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.